skip to main content

HBV Post-Transplant Prophylaxis — SCE Infectious Diseases MCQ

Instant feedback + full explanation. One question, done properly.

HardHepatitisHBV Post-Transplant ProphylaxisSCE Infectious Diseases

A 45-year-old man with cirrhosis (Child-Pugh C) is listed for liver transplant. His hepatitis B serology shows: HBsAg positive, HBeAg negative, anti-HBe positive, HBV DNA <20 IU/mL on Entecavir. He undergoes transplantation successfully. What HBV prophylaxis is needed post-transplant?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: ALifelong HBIG plus nucleos(t)ide analogue (or nucleos(t)ide analogue alone in some protocols) to prevent HBV recurrence in the graft

Post-liver transplant for HBV-related disease, HBV recurrence in the new graft is a major risk. Prophylaxis with HBIG (hepatitis B immunoglobulin) plus a nucleos(t)ide analogue (Entecavir or Tenofovir) is the standard approach, often lifelong. Some centres now use nucleos(t)ide analogue monotherapy after an initial period of HBIG. Without prophylaxis, HBV recurrence rates exceed 80%. The goal is to maintain undetectable HBV DNA and adequate anti-HBs levels.

Reference: https://www.nice.org.uk/guidance/conditions-and-diseases/infections